Prodia, Domestically-Owned Company Traded on Indonesian Stock Exchange

PT Prodia Widyahusada Tbk has officially registered its stocks on the Indonesian Stock Exchange (IDX) since December 7, 2016 by offering 20% of its stocks to public with the majority of the shareholder remaining at the domestic holding company owned by the founders. As for the 20% publicly traded stocks, they may be owned by both domestic and foreign investors.

Ensuring the sustainability and development of Prodia's services is the founders' underlying idea behind the release of 20% of their stocks to public. The funds obtained from the IPO are to be used for expanding Prodia Clinical Laboratory's services throughout Indonesia, to reach and serve all Indonesian people.

Besides, Prodia plans to develop laboratory tests to support next generation healthcare that will allow it to be both a leader in its home country and on a par with laboratories abroad. In line with the free trade economy (AEC) commenced in 2015, Prodia is prepared to compete with both its overseas and in-country counterparts.

Consistent with Prodia's mission, "For Better Diagnoses", we put the utmost importance on our customers' test results quality and medical information security.

PT Prodia Widyahusada Tbk

For official information, please contact us by email at:

corporate.secretary@prodia.co.id